ISSN: 2161-0932
						Alessia  Re
	
					    												
Italy						                            
                            
						
 Research Article
												Gene Profiling and Therapy: What's the Future? A Case Report of Uterine Leiomyosarcoma 						
Author(s): Alessia  Re, Anna Rita  Alitto, Ciro  Mazzarella, Francesco  Catucci, Antonella  Martino, Giovanna  Mantini and Giovanni  PalazzoniAlessia  Re, Anna Rita  Alitto, Ciro  Mazzarella, Francesco  Catucci, Antonella  Martino, Giovanna  Mantini and Giovanni  Palazzoni             
						
												
				 Background: Uterine leiomyosarcomas (uLMS), although rare (3%-7% of all uterine malignancies), represent an important share of mortality due to uterine pathology. Surgery is the cornerstone of treatment but the lack of data from randomized clinical trials makes the function of adjuvant therapy still nebulous. For these reasons, the treatment of the uLMS is still a challenge in progress.Case presentation: We report the case of 72-years old woman who underwent several lines of therapy. After systemic disease progression, was subjected to a genetic test that showed a mutation of CDKN2A. Basing on these results, the patient started Palbociclib, which is still ongoing.Conclusion: The choice of drug was based on the presence of the patient’s specific mutation and not on therapeutic options recommended by guidelines. In thi.. View More»
				  
												DOI:
												 10.4172/2161-0932.1000498